Clinical trial
A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease…
NCT00464308 · Janssen-Cilag Pty Ltd, Industry · Completed
Key facts
| NCT number | NCT00464308 |
|---|---|
| Title | A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg |
| Official title | The Rabeprazole and Esomeprazole Reflux Assessment Trial (TREAT) |
| Lead sponsor | Janssen-Cilag Pty Ltd, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastro-oesophageal Reflux |
| Intervention type | Drug |
| Interventions | Esomeprazole, Rabeprazole |
| Enrollment | 1,392 |
| Start date | Nov 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Apr 23, 2007 |
| Last update posted | Apr 21, 2014 |
| Countries | Australia |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: